To confirm the role of PITPNM3 in naive CD4+ T cell recruitment to breast tumors and elucidate the role of naive CD4+ T cell infiltration in Treg generation and cancer progression in vivo, we employed a humanized mouse tumor model. This evidence concerns the gene CD4 and cancer.